AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04716192 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial release technique & Ultrasound
Description: Myofascial Release Technique~* Position of the patient - sitting comfortably with supported back, elbow flexed with forearm placed on a pillow. A low load, long duration stretch is applied along the lines of maximal fascial restrictions. The fascia is palpated and the pressure is applied directly to the skin, into the direction of restriction just until resistance (tissue barrier) is felt. The pressure will be applied for 90 to120 seconds. This procedure will carried out without sliding over the skin or forcing the tissue until the fascia complex starts to yield and a sensation of softening is achieved.~* Therapeutic ultrasound with the frequency of 3Mhz , with continuous mode and an intensity of 0.1-1.5 W/cm2 for a duration of 5 min will given with the patient position back rest.
Study NCT05860140 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education video
Description: Six minutes long education video focusing on protein and energy meals
Study NCT05307666 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medication minimization
Description: During the medication minimization visit, and any necessary follow-up visits, patients and providers work together to gradually minimize medication dosages (e.g. reducing 1/4 or 1/2 dose at a time) using the following approach: 1) Medications Treating Symptoms: Find the minimum dose that controls the symptom, 2) Drugs that Lower Blood Pressure: Reduce dosages until systolic BP is in the upper 10mmHg of the target range (e.g. target 130 - 140 mmHg), 3) Drugs That Lower Blood Sugar: Reduce dosages until HbA1c is in the upper 5% of the target range (e.g. target 7.5 - 8.0%).
Study NCT06461637 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stepped Care Mental Health for Foreign Domestic Helpers (SCMH-FDH)
Description: The SCMH-FDH intervention consists of 4 steps. Step 1 involves a self-help intervention (through 12 mental health booklets) delivered in 6 sessions and an online peer support group. Those who did not respond to Step 1 will be referred to Step 2 (group-based resilience workshop). The intervention will be also be delivered in 6 weekly sessions lasting 1-1.5-hours. Those who did not respond to Step 2 will be referred to Step 3 (guided self-help cognitive behavioral therapy, CBT) with guidance from a trained therapist. Self-help materials will be provided. The sessions are spread out over six weeks, with each sessions lasting 30-45 minutes. Those who did not respond to Step 3 will be referred to Step 4 (high intensity interventions provided by mental health professionals). Stepping up is determined by the IAPT-minimum data set. If assessment scores after previous treatment exceeds the defined threshold (PHQ-9 ≥ 10 or GAD-7 ≥ 8), then participants need to step up to the next intervention.
Study NCT04812171 — intervention group
Intervention type: PROCEDURE
Intervention: non-surgical endodontic treatment
Description: standard non-surgical endodontic treatment performed by endodontic specialist
Study NCT05186883 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogenic parathyroid cells
Description: Allogenic parathyroid cells
Study NCT05186883 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard treatment according to the Clinical protocols
Description: Standard treatment of postoperative hypoparathyroidism according to the Clinical protocols
Study NCT05186883 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard treatment according to the Clinical protocols
Description: Standard treatment of postoperative hypoparathyroidism according to the Clinical protocols
Study NCT04124029 — intervention group
Intervention type: PROCEDURE
Intervention: No intervention is used for this study but all subjects will be asked to complete a venous blood draw procedure and a lumbar puncture procedure.
Description: No intervention will be used.
Study NCT04300023 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Cycling Group
Description: engaged with a research staff member for 30 minutes of cycling
Study NCT05227066 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: adding lower extremity weights
Description: All children in the two groups received physical therapy protocol for 30 minutes in addition to half kg of sandbags weights attached for each leg
Study NCT05227066 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traditional physical therapy group
Description: traditional physical therapy group
Study NCT05524311 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baricitinib
Description: Oral tablets (2 mg) will be used For children > or = 6 years: 4 mg once a day (2 x 2 mg) during the 24 weeks-period study For children \< 6 years: 2 mg once a day during the 24 weeks -period study
Study NCT06468982 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intra-aortic Balloon Pump
Description: in patients with acute myocardial infarction involving elevated troponin levels and recurrent or persistent chest pain at rest, hemodynamic instability, multivessel disease, left main coronary artery disease, and narrow and/or tortuous coronary artery anatomy in which PCI has failed or is not feasible.
Study NCT06661746 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Multimodal IV analgesia
Description: Multimodal IV analgesia of lidocaine, ketamine and MS
Study NCT06661746 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: epidural analgesia
Description: Opioid-based and epidural analgesia
Study NCT06747819 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cervical Epidural Steroid Injection (CESI)
Description: Participants in this group received CESI to reduce inflammation and alleviate pain in the cervical nerve roots.
Study NCT06747819 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Neural Mobilization (NM)
Description: Participants in this group underwent NM exercises aimed at improving nerve mobility and reducing symptoms related to nerve compression.
Study NCT05212571 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: S-ketamine infusion inpatient setting
Description: S-ketamine is administered intravenously for six consecutive days. The administered dose of S-ketamine is 50 mcg/kg/h and can be increased to a maximum of 200 mcg/kg/h.
Study NCT05212571 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-ketamine infusion outpatient setting
Description: S-ketamine is administered intravenously for six hours. The administered dose of S-ketamine is 50 mcg/kg/h and can be increased to a maximum of 200 mcg/kg/h.
Study NCT05876130 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: POHIM_EM
Description: hypofractionated intensity-modulated radiation therapy (2.5 Gy/fraction, 16 fractions)
Study NCT03615248 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BreatheSuite
Description: BreatheSuite (patent pending) is a device and mobile application developed by Mr. Brett Vokey, an engineering student at Memorial University of Newfoundland. BreatheSuite has been recognized by numerous provincial competitions, featured at the Eastern Health Innovation Showcase, and was recently selected as a finalist for the New York Health Innovation Challenge.~This device attaches to metered dose inhalers and it can determine if:~1. the dose was given,~2. the metered dose inhaler was properly shaken,~3. the metered dose inhaler is properly aligned,~4. the flow of medication is appropriate and~5. there is no accidental exhalation into the inhaler.
Study NCT05142332 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Covid-19 vaccine education materials
Description: videos and flyers containing Covid-19 vaccine educational information
Study NCT05200247 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: spesolimab
Description: solution for infusion
Study NCT06242899 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Exercise with a cycle ergometer in three phases:~* Warm-up: the exercise intensity was determined at 50-60% of HRmax obtained in the effort test, and lasted 2 minutes.~* Short exercise at moderate intensity for 8, 10 or 15 minutes according to group allocation. The exercise was cycling at 75% HRmax determined with an effort test.~* Cool down: the exercise intensity was determined at 50-60% of HRmax obtained in the effort test, and lasted 2 minutes.
Study NCT05524311 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: pharmacokinetics study
Description: additionnal blood sampling at week 4, 8, 12, and 24
Study NCT05524311 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: dosage of cytokines
Description: additionnal blood sampling at weeks 0, 4 and 24
Study NCT05524311 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: transcriptomic analysis
Description: additionnal blood sampling at weeks 0, 4 and 24
Study NCT05524311 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent version of the Child Health Questionnaire (CHQ)
Description: Evaluate by parents at each visits
Study NCT05524311 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Childhood Health Assessment Questionnaire
Description: Evaluate by parents at each visits
Study NCT05524311 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pregnancy test
Description: Urine pregnancy test at V4 A dosage of bHCG with current biological analysis is done at each visit (except V4)
Study NCT05528861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lirentelimab (AK002)
Description: Lirentelimab (AK002) is a humanized non-fucosylated immunoglobulin G1 (IgG1) monoclonal antibody directed against Siglec-8
Study NCT05528861 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05373342 — intervention group
Intervention type: DEVICE
Intervention: iCount system assembled with swabs
Description: Designed as single use. Intended purpose - To be used to count swabs and tampons after childbirth in an objective manner. This is intended to be used in women during and after childbirth.
Study NCT05443828 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Breakfast Control Meal
Description: The participants consumed extruded puff with added vitacel (cellulose) as part of the breakfast meal (400 kcal, 12 g fiber) followed by consumption of standardised meal at lunch and dinner . The lunch and dinner did noft contain any intervention products. Blood samples were collected at 14 timepoints drawn (first sample 15 minutes before breakfast, last sample 24 hours after breakfast), during 6 hours after the test breakfast meal and during other 2 hours after standardised lunch.
Study NCT05443828 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breakfast Test Meal
Description: The participants consumed bread with added arabynoxylans (AX) as part of the breakfast meal (400 kcal, 12 g fiber) followed by consumption of standardised meal at lunch and dinner . The lunch and dinner did noft contain any intervention products. Blood samples were collected at 14 timepoints drawn (first sample 15 minutes before breakfast, last sample 24 hours after breakfast), during 6 hours after the test breakfast meal and during other 2 hours after standardised lunch.
Study NCT05443828 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breakfast Test Meal
Description: The participants consumed extruded puff with added wheat bran as part of the breakfast meal (400 kcal, 12 g fiber) followed by consumption of standardised meal at lunch and dinner . The lunch and dinner did noft contain any intervention products. Blood samples were collected at 14 timepoints drawn (first sample 15 minutes before breakfast, last sample 24 hours after breakfast), during 6 hours after the test breakfast meal and during other 2 hours after standardised lunch.
Study NCT06237868 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: rTMS Active
Description: The participants undergo Active rTMS, approximately 10-15 min and then complete tasks and questionnaires.
Study NCT06237868 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: rTMS Sham
Description: The participants undergo Sham rTMS, approximately 10-15 min and then complete tasks and questionnaires.
Study NCT05657847 — intervention group
Intervention type: DEVICE
Intervention: Photon-counting detector-CT
Description: CT scan
Study NCT06388629 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rook Epicardial Access Kit
Description: Access the epicardial surface of the heart via a subxiphoid approach with the subject device to facilitate guidewire placement into the pericardium.
Study NCT06109935 — intervention group
Intervention type: DRUG
Intervention: Somapacitan
Description: Sogroya® treatment regimen will be in accordance with the approved product labelling in Japan.
Study NCT06266546 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: Prophylactic tranexamic acid will be instilled via endobronchial route in all patients undergoing transbronchial cryobiopsy. The medication will be administered through the bronchoscope one minute prior to the cryobiopsy. 500 mg of TXA diluted in 10 ml of saline and the procedure would be carried out as usual.
Study NCT05970328 — intervention group
Intervention type: DEVICE
Intervention: Hexoskin Medical System
Description: Participant wears both the Hexoskin Medical System and the Nasiff Holter Monitor at the same time to acquire ECG recordings.
Study NCT05554679 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: Metformin is an oral insulin-sensitising medication that acts to decrease blood glucose concentrations. It inhibits pathways in the liver that stimulate glucose production and also acts to increase glucose uptake into skeletal muscle and fat cells . Metformin is commonly used in the treatment of type 2 diabetes mellitus and polycystic ovarian syndrome , and is being used increasingly in the treatment of gestational diabetes, having been shown to result in decreased rates of neonatal hypoglycaemia and no increased risk of adverse maternal outcomes when compared with insulin.
Study NCT06274957 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CONTROL
Description: Pursed Lips breathing exercise, Active Respiratory Techniques Cycle, Postural Drainage, Mobilization, Calisthenic Exercises, and Patient Education. Relaxation positions and energy conservation techniques were taught in Patient Education
Study NCT06274957 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PEP DEVICE
Description: Pursed Lips breathing exercise, Active Respiratory Techniques Cycle, Postural Drainage, Mobilization, Calisthenic Exercises, and Patient Education. Relaxation positions and energy conservation techniques were taught in Patient Education~PEP training was applied using the Acapella device.~In addition, participants were subjected to two sessions of 10 minutes each with the Acapella device. In the study, the Acapella device, capable of sustaining expiratory flow of at least 15 L/min for 3 seconds, was activated by taking a deep breath, holding the breath for 2-3 seconds, and then exhaling into the device.
Study NCT06274957 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HFCWO DEVICE
Description: Patients were provided with conventional exercises including Pursed Lips breathing exercise, Active Respiratory Techniques Cycle, Postural Drainage, Mobilization, Calisthenic Exercises, and Patient Education. Relaxation positions and energy conservation techniques were taught in Patient Education~In addition, participants will receive High-Frequency Chest Wall Oscillation (HFCWO) therapy twice a day for 10 minutes each.~HFCWO training was applıed using the WEST device
Study NCT05382156 — intervention group
Intervention type: DRUG
Intervention: Osilodrostat
Description: oral administration of Osilodrostat tablets at different doses according to patient's need
Study NCT05092750 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FerroTraceTM
Description: A magnetic
Study NCT05092750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: indocyanine green (ICG)
Description: Given by SC injection
Study NCT05683366 — intervention group
Intervention type: DEVICE
Intervention: No Intervention
Description: There is no intervention in this study
Study NCT04759014 — intervention group
Intervention type: OTHER
Intervention: The effect of using two different prosthetic feet on functional capacity, pain severity, satisfaction level and quality of life
Description: The effect of using two different prosthetic feet on functional capacity, pain severity, satisfaction level and quality of life
Study NCT05929144 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MRI sequences testing
Description: Testing different MRI sequences in order to optimize them
Study NCT06186882 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Action Video-Game
Description: Thanks to their specific characteristics (presentation of multiple peripheral, rapidly moving, spatio-temporally unpredictable stimuli), Action Video-Games improve reading skills through their effects on the Magnocellular-Dorsal stream. Training will consist of 20 days of Action Video-Games sessions of 1 hour each, three times per week.
Study NCT05395832 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TAU + multicomponent treatment VIRTUAL FIBROWALK + 4 face-to-face sessions at sea
Description: Group treatment protocol of 12 weekly 60 minute virtual sessions. All sessions include the following ingredients (approx. in the same order):~Pain neuroscience education (15 min.) Cognitive restructuring (15 min.) Mindfulness techniques (15 min.) Physical exercise(15 min.) Treatment as Usual (TAU) 4 face-to-face sessions (1 per mounth) at sea Standard pharmacological treatment usually provided to patients with fibromyalgia.
Study NCT05395832 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU + multicomponent treatment VIRTUAL FIBROWALK + 4 face-to-face sessions in nature
Description: Group treatment protocol of 12 weekly 60 minute virtual sessions. All sessions include the following ingredients (approx. in the same order):~Pain neuroscience education (15 min.) Cognitive restructuring (15 min.) Mindfulness techniques (15 min.) Physical exercise(15 min.) Treatment as Usual (TAU) 4 face-to-face sessions (1 per mounth) in nature Standard pharmacological treatment usually provided to patients with fibromyalgia.
Study NCT05395832 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU + multicomponent treatment VIRTUAL FIBROWALK
Description: Group treatment protocol of 12 weekly 60 minute virtual sessions. All sessions include the following ingredients (approx. in the same order):~Pain neuroscience education (15 min.) Cognitive restructuring (15 min.) Mindfulness techniques (15 min.) Physical exercise(15 min.) Treatment as Usual (TAU) Standard pharmacological treatment usually provided to patients with fibromyalgia.
Study NCT04662840 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Geniculate artery embolization
Description: Under fluoroscopic guidance and angiographic imaging, a microcatheter is used to select all the arteries feeding the affected knee and Embosphere (100-300um) particles are injected to obtaining pruning of the hypervascular tissues arteries.
Study NCT04662840 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Geniculate nerve ablation
Description: Under fluoroscopic guidance, a Cool-tip RFA ablation needle is advanced such that it touches the femur at the condylar convexity on each side and the tibia at the tibial plateau convexity on the medial side. The ablation is performed to obtain an approximate zone of ablation of 2cm.
Study NCT04662840 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Skin infiltration of local anesthetic at groin and knee
Description: Freezing of the skin will be performed at the groin (as prior to an arterial access for embolization procedure) and at three areas around the knee (as prior to insertion of the ablation needles for nerve ablation procedure).
Study NCT04662840 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Skin infiltration of local anesthetic at groin and knee
Description: Freezing of the skin will be performed at the groin (as prior to an arterial access for embolization procedure) and at three areas around the knee (as prior to insertion of the ablation needles for nerve ablation procedure).
Study NCT05189340 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Videos
Description: Series of six videos each covering a specific aspect of post-transplant care related to medication use or monitoring
Study NCT05714358 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education
Description: * The patients were given face-to-face training on nutrition, physical activity and drug use in chronic renal failure .~* After the training, the biochemical parameters of the patients were followed for 6 months.~* In this process, the questions asked by the patients in order not to hinder their right to receive information were answered.
Study NCT05518734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-708
Description: Solution for intravenous (IV) administration.
Study NCT05518734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Solution for oral administration.
Study NCT05518734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Solution for oral administration.
Study NCT05518734 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo matched to VX-708 for IV administration.
Study NCT05945667 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Monural
Description: 1 sachet, only 1st day of trial
Study NCT05945667 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Monural
Description: 1 sachet, only 1st day of trial
Study NCT05945667 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: UroNext
Description: 1 sachet per day for the first 7 days, followed by 7 days break Same scheme to be repeated for 3 months